Influenza A virus (H3N2) (ATCC® VR-777)

Classification: Orthomyxoviridae, Influenzavirus A  /  Product Format: frozen

Classification Orthomyxoviridae, Influenzavirus A
Deposited As Influenza A virus
Agent Influenza A virus (H3N2)
Strain MRC 2
Applications
Influenza Research
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
human (recombinant A/England/42/72 and A/PR8/34 influenza strains)
Product Format frozen
Storage Conditions -70°C or colder
Comments
Hemagglutinin and neuraminidase antigens identical to strain A/England/42/72, i.e. H(3)N(2) type. Unrelated to A/PR8/34 (Honi).
Effect on Host
Yes, in vitro effects: Hemagglutination activity
Hemagglutinates chicken RBC and guinea pig RBC.
Recommended Host
10 day chicken embryo, i.a. inoculation

Recommended Host:  SPF CE (10 to 11 day, intra-allantoic)

<
chicken embryo
Growth Conditions
Temperature: 37.0°C
Duration: 1-4 days
Effect on Host
Yes, in vitro effects: Hemagglutination activity
Hemagglutinates chicken RBC and guinea pig RBC.
Name of Depositor R.I.T. - Recherche et Industrie Therapeutiques
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Source
human (recombinant A/England/42/72 and A/PR8/34 influenza strains)
References

Peetermans J. Live influenza virus vaccines and preparation thereof. US Patent 3,953,592 dated Apr 27 1976